Health Care Deal News- July 9, 2012

 

Brought to you by www.DealSearchOnline.com
 

July 9, 2012 Issue:

 

  1. Recent Health Care M&A Deals 
  2. Spotlight on: Long-Term Care
  3. Spotlight on: Biotechnology
  4. Conference Calendar

Recent Health Care M&A Deals

BIOTECHNOLOGY

Acquirer

Target

Price

 Vitrolife

 Cryo Management LTD

 $6.29 million

LABORATORIES, MRI AND DIALYSIS

Acquirer

Target

Price

 Pernix Therapeutics Holdings, Inc.

 Great Southern Laboratories

 $4.9 million

MANAGED CARE

Acquirer

Target

Price

 Detroit Medical Center

 ProCare Health Plan, Inc. (HMO)

 $6.0 million

MEDICAL DEVICES

Acquirer

Target

Price

 Sorin Group

 California Medical Laboratories, Inc. (CalMed)

 $14.0 million

PHARMACEUTICALS

Acquirer

Target

Price

 Bristol-Myers Squibb

 Amylin Pharmaeuticals

 $7.0 billion

 

How can we serve you better? Complete our brief survey for a chance to win $250 from AMEX!
What is most important to your business? Is there something you would like to see in one of our publications? We are dedicated to being an integral part of keeping your business ahead of the competition. We would love to hear from you. Fill out our brief publications survey and you will be entered for a chance to win one of two $250 American Express gift cards! http://www.levinassociates.com/pubsurvey

 

Spotlight on: Long-Term Care
In May’s largest Long-Term Care Deal, Bristal Holdings is selling a portfolio of five seniors living communities in New York State. Bristal is jointly owned by Chartwell Seniors Housing REIT (TSX: CSH-UN) and ING Real Estate Australia Pty. The purchase price is approximately $290.0 million.......Read more
 

 

Is Your Company a Power User of Merger and Acquisition Data?
Drive the price of data down to less than 3 cents per item. Call 1-800-248-1668 to learn about our frequency discounts. Go to http://www.dealsearchonline.com, an easy-to-use, award-winning database. This specialized database is an essential 24/7 source for details on health care mergers and acquisitions covering 13 sectors. With approximately 20,000 records of investments and contact names (including e-mail addresses), you’ll get the information you need to make an informed decision any time of the day or night. Call 1-800-248-1668 to learn about our frequency discounts.

 

Spotlight on: Biotechnology
Abbott Laboratories (NYSE: ABT) is entering into an agreement with Action Pharma A/S to develop and commercialize Action’s AP214, a compound to prevent acute kidney injury associated with major cardiac surgery. Under terms of the deal, ABT will pay Action, a company based in Denmark, $110.0 million upfront........Read more

 
Conference Calendar...Click here to see more